Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

Graphical abstract

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of hepatology 2015-02, Vol.62 (2), p.363-370
Hauptverfasser:	Papatheodoridis, George V, Dalekos, George N, Yurdaydin, Cihan, Buti, Maria, Goulis, John, Arends, Pauline, Sypsa, Vana, Manolakopoulos, Spilios, Mangia, Giampaolo, Gatselis, Nikolaos, Keskın, Onur, Savvidou, Savvoula, Hansen, Bettina E, Papaioannou, Christos, Galanis, Kostantinos, Idilman, Ramazan, Colombo, Massimo, Esteban, Rafael, Janssen, Harry L.A, Lampertico, Pietro
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenine - analogs & derivatives Adenine - therapeutic use Adult Antiviral Agents - therapeutic use Carcinoma, Hepatocellular - ethnology Carcinoma, Hepatocellular - etiology Cirrhosis CU-HCC Entecavir European Continental Ancestry Group Female Follow-Up Studies GAG-HCC Gastroenterology and Hepatology Greece - epidemiology Guanine - analogs & derivatives Guanine - therapeutic use Hepatitis B Hepatitis B, Chronic - drug therapy Hepatitis B, Chronic - ethnology Hepatocellular carcinoma Humans Incidence Liver Neoplasms - ethnology Liver Neoplasms - etiology Male Middle Aged Netherlands - epidemiology Organophosphonates - therapeutic use REACH-B Retrospective Studies Reverse Transcriptase Inhibitors - therapeutic use Risk Factors Risk scores Spain - epidemiology Tenofovir Time Factors Turkey - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!